Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
Recruiting
Phase 2
Interventional Study
Cervical Lesion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 45 and older
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 85 (estimated)
- Sponsor
- Centre Oscar Lambret · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single-center, Phase II interventional study evaluating secondary HPV vaccination after treatment of high-grade cervical lesions. The study aims to estimate the rate of HPV clearance within two years following an initial positive HPV control test in women over 45 years of age who are chronic HPV carriers and have undergone treatment for high-grade intraepithelial cervical lesions, and wh…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Common eligibility criteria for the study (for both cohorts) :
1. Female patient over 45 years old
2. Patient treated by conization for high-grade cervical epithelial lesion
3. Positive HPV test at the 6-month post-operative control (a delay of 6 to 12 months will b…
Contacts